BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 12167712)

  • 1. Gamma interferon and cadmium treatments modulate eukaryotic initiation factor 4E-dependent mRNA transport of cyclin D1 in a PML-dependent manner.
    Topisirovic I; Capili AD; Borden KL
    Mol Cell Biol; 2002 Sep; 22(17):6183-98. PubMed ID: 12167712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aberrant eukaryotic translation initiation factor 4E-dependent mRNA transport impedes hematopoietic differentiation and contributes to leukemogenesis.
    Topisirovic I; Guzman ML; McConnell MJ; Licht JD; Culjkovic B; Neering SJ; Jordan CT; Borden KL
    Mol Cell Biol; 2003 Dec; 23(24):8992-9002. PubMed ID: 14645512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The N and C termini of the splice variants of the human mitogen-activated protein kinase-interacting kinase Mnk2 determine activity and localization.
    Scheper GC; Parra JL; Wilson M; Van Kollenburg B; Vertegaal AC; Han ZG; Proud CG
    Mol Cell Biol; 2003 Aug; 23(16):5692-705. PubMed ID: 12897141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phosphorylation of eukaryotic initiation factor 4E is dispensable for skeletal muscle hypertrophy.
    Figueiredo VC; Englund DA; Vechetti IJ; Alimov A; Peterson CA; McCarthy JJ
    Am J Physiol Cell Physiol; 2019 Dec; 317(6):C1247-C1255. PubMed ID: 31596607
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The promyelocytic leukemia protein PML has a pro-apoptotic activity mediated through its RING domain.
    Borden KL; CampbellDwyer EJ; Salvato MS
    FEBS Lett; 1997 Nov; 418(1-2):30-4. PubMed ID: 9414089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Control of cyclin-dependent kinase inhibitor p27 expression by cap-independent translation.
    Miskimins WK; Wang G; Hawkinson M; Miskimins R
    Mol Cell Biol; 2001 Aug; 21(15):4960-7. PubMed ID: 11438653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Translation initiation factor 4E (eIF4E) is regulated by cell death inhibitor, Diap1.
    Lee SK; Lee JS; Shin KS; Yoo SJ
    Mol Cells; 2007 Dec; 24(3):445-51. PubMed ID: 18182863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A role for eIF4E and eIF4E-transporter in targeting mRNPs to mammalian processing bodies.
    Andrei MA; Ingelfinger D; Heintzmann R; Achsel T; Rivera-Pomar R; Lührmann R
    RNA; 2005 May; 11(5):717-27. PubMed ID: 15840819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nuclear body movement is determined by chromatin accessibility and dynamics.
    Görisch SM; Wachsmuth M; Ittrich C; Bacher CP; Rippe K; Lichter P
    Proc Natl Acad Sci U S A; 2004 Sep; 101(36):13221-6. PubMed ID: 15331777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The eukaryotic translation initiation factor eIF4E unexpectedly acts in splicing thereby coupling mRNA processing with translation: eIF4E induces widescale splicing reprogramming providing system-wide connectivity between splicing, nuclear mRNA export and translation.
    Borden KLB
    Bioessays; 2024 Jan; 46(1):e2300145. PubMed ID: 37926700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Zinc controls PML nuclear body formation through regulation of a paralog specific auto-inhibition in SUMO1.
    Lussier-Price M; Wahba HM; Mascle XH; Cappadocia L; Bourdeau V; Gagnon C; Igelmann S; Sakaguchi K; Ferbeyre G; Omichinski JG
    Nucleic Acids Res; 2022 Aug; 50(14):8331-8348. PubMed ID: 35871297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell organelles as targets of mammalian cadmium toxicity.
    Lee WK; Thévenod F
    Arch Toxicol; 2020 Apr; 94(4):1017-1049. PubMed ID: 32206829
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nuclear eIF4E Stimulates 3'-End Cleavage of Target RNAs.
    Davis MR; Delaleau M; Borden KLB
    Cell Rep; 2019 Apr; 27(5):1397-1408.e4. PubMed ID: 31042468
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The RNA-Binding Protein, Polypyrimidine Tract-Binding Protein 1 (PTBP1) Is a Key Regulator of CD4 T Cell Activation.
    La Porta J; Matus-Nicodemos R; Valentín-Acevedo A; Covey LR
    PLoS One; 2016; 11(8):e0158708. PubMed ID: 27513449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deletion of Methionine Sulfoxide Reductase A Does Not Affect Atherothrombosis but Promotes Neointimal Hyperplasia and Extracellular Signal-Regulated Kinase 1/2 Signaling.
    Klutho PJ; Pennington SM; Scott JA; Wilson KM; Gu SX; Doddapattar P; Xie L; Venema AN; Zhu LJ; Chauhan AK; Lentz SR; Grumbach IM
    Arterioscler Thromb Vasc Biol; 2015 Dec; 35(12):2594-604. PubMed ID: 26449752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The eukaryotic translation initiation factor eIF4E in the nucleus: taking the road less traveled.
    Osborne MJ; Borden KL
    Immunol Rev; 2015 Jan; 263(1):210-23. PubMed ID: 25510279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Upregulation of the cell-cycle regulator RGC-32 in Epstein-Barr virus-immortalized cells.
    Schlick SN; Wood CD; Gunnell A; Webb HM; Khasnis S; Schepers A; West MJ
    PLoS One; 2011; 6(12):e28638. PubMed ID: 22163048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The translation initiation factor eIF4E regulates the sex-specific expression of the master switch gene Sxl in Drosophila melanogaster.
    Graham PL; Yanowitz JL; Penn JK; Deshpande G; Schedl P
    PLoS Genet; 2011 Jul; 7(7):e1002185. PubMed ID: 21829374
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Understanding and Targeting the Eukaryotic Translation Initiation Factor eIF4E in Head and Neck Cancer.
    Culjkovic B; Borden KL
    J Oncol; 2009; 2009():981679. PubMed ID: 20049173
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.